Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 3/20 | 0.52 |
| ▸ | CES1 | P23141 | 3/20 | 0.52 |
| ▸ | PPARG | P37231 | 8/20 | 0.52 |
| ▸ | PPARA | Q07869 | 8/20 | 0.52 |
| ▸ | PPARD | Q03181 | 6/20 | 0.50 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.50 |
| ▸ | TSHR | P16473 | 4/20 | 0.50 |
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.50 |
| ▸ | FABP4 | P15090 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | TLR2 | O60603 | 2/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.50 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.50 |
| ▸ | TERT | O14746 | 2/20 | 0.50 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.50 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.50 |
| ▸ | GMNN | O75496 | 1/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3212902 | 1.00 | CES2 (0.52) | CES2CES1PPARGPPARAPPARD | |
| SCHEMBL30675 | 1.00 | CES2 (0.52) | CES2CES1PPARGPPARAPPARD | |
| SCHEMBL788432 | 1.00 | CES2 (0.52) | CES2CES1PPARGPPARAPPARD | |
| SCHEMBL3512333 | 1.00 | CES2 (0.52) | CES2CES1PPARGPPARAPPARD | |
| SCHEMBL7180871 | 1.00 | CES2 (0.52) | CES2CES1PPARGPPARAPPARD | |
| SCHEMBL3330873 | 0.98 | TRPA1 (0.52) | CES2CES1PPARGPPARAPPARD | |
| SCHEMBL3397001 | 0.95 | PPARG (0.56) | CES2CES1PPARGPPARAPPARD | |
| SCHEMBL624501 | 0.95 | PPARG (0.56) | CES2CES1PPARGPPARAPPARD | |
| SCHEMBL1173224 | 0.95 | PPARG (0.56) | CES2CES1PPARGPPARAPPARD | |
| SCHEMBL9868698 | 0.95 | PPARG (0.56) | CES2CES1PPARGPPARAPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 179 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11873520-B2 | Production of malonyl-COA derived products via anaerobic pathways | LALLEMAND HUNGARY LIQUIDITY MANAGEMENT LLC (HU) | 2024-01-16 | — | — | US | claimed |
| US-10174350-B2 | Genetically modified microorganism for producing medium-chain lauric acid and/or dodecanedioic acid and method of using thereof | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2019-01-08 | — | — | US | claimed |
| US-10138504-B2 | Production of malonyl-CoA derived products via anaerobic pathways | LALLEMAND HUNGARY LIQUIDITY MANAGEMENT LLC (HU) | 2018-11-27 | — | — | US | claimed |
| US-20170191092-A1 | Genetically Modified Microorganism For Producing medium-chain lauric acid and/or dodecanedioic acid And Method of Using Thereof | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2017-07-06 | — | — | US | claimed |
| US-9695404-B2 | Genetically modified microorganism for producing long-chain dicarboxylic acid and method of using thereof | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2017-07-04 | — | — | US | claimed |
| US-20160017387-A1 | GENETICALLY MODIFIED MICROORGANISM FOR PRODUCING LONG-CHAIN DICARBOXYLIC ACID AND METHOD OF USING THEREOF | IND TECH RES INST (TW) | 2016-01-21 | — | — | US | claimed |
| EP-0778896-B1 | NUCLEOTIDES SEQUENCES OF CANOLA AND SOYBEAN PALMITOYL-ACP THIOESTERASE GENES AND THEIR USE IN THE REGULATION OF FATTY ACID CONTENT OF THE OILS OF SOYBEAN AND CANOLA PLANTS | DU PONT (US) | 2015-01-07 | — | — | EP | claimed |
| US-20130323766-A1 | Production of Malonyl-CoA Derived Products Via Anaerobic Pathways | MASCOMA CORPORATION (US) | 2013-12-05 | — | — | US | claimed |
| WO-2012019175-A2 | PRODUCTION OF MALONYL-COA DRIVED PRODUCTS VIA ANAEROBIC PATHWAYS | MASCOMA CORPORATION (US) | 2012-02-09 | — | — | WO | claimed |
| WO-1996013591-A9 | METHODS AND COMPOSITIONS RELATING TO PLANT Δ6 PALMITOYL-ACYL CARRIER PROTEIN DESATURASE | — | 1996-09-12 | — | — | WO | claimed |
| WO-1996013591-A2 | METHODS AND COMPOSITIONS RELATING TO PLANT Δ6 PALMITOYL-ACYL CARRIER PROTEIN DESATURASE | MICHIGAN STATE UNIVERSITY (US) | 1996-05-09 | — | — | WO | claimed |
| CN-118304253-A | Sustained release preparation composition | 南京清普生物科技有限公司 | 2024-07-09 | — | — | CN | disclosed |
| US-11964014-B2 | Vaccine adjuvants based on TLR receptor ligands | THE UNIVERSITY OF MONTANA (US) | 2024-04-23 | — | — | US | disclosed |
| US-20240117392-A1 | ENGINEERED BACTERIA AND METHODS OF PRODUCING TRIACYLGLYCERIDES | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2024-04-11 | — | — | US | disclosed |
| CN-114762676-B | Sustained release preparation composition | 南京清普生物科技有限公司 | 2024-03-08 | — | — | CN | disclosed |
| US-5614400-A | INTRODUCTION OF A DOUBLE BOND IN THE SIXTH CARBON ATOM OF PALMITIC ACID | MICHIGAN STATE UNIVERSITY (US) | 1997-03-25 | — | — | US | disclosed |
| WO-1996013591-A9 | METHODS AND COMPOSITIONS RELATING TO PLANT Δ6 PALMITOYL-ACYL CARRIER PROTEIN DESATURASE | — | 1996-09-12 | — | — | WO | disclosed |
| WO-1996013591-A3 | METHODS AND COMPOSITIONS RELATING TO PLANT Δ6 PALMITOYL-ACYL CARRIER PROTEIN DESATURASE | UNIV MICHIGAN STATE (US) | 1996-08-08 | — | — | WO | disclosed |
| WO-1996013591-A2 | METHODS AND COMPOSITIONS RELATING TO PLANT Δ6 PALMITOYL-ACYL CARRIER PROTEIN DESATURASE | MICHIGAN STATE UNIVERSITY (US) | 1996-05-09 | — | — | WO | disclosed |
| US-4018806-A | FRACTIONAL CRYSTALLIZATION | THE PROCTER & GAMBLE COMPANY (US) | 1977-04-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11964014-B2 | Vaccine adjuvants based on TLR receptor ligands | TLR7, TLR9, TLR8 | CES2 4608/4885CES1 3199/4885PPARG 290/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.